Chen‐Xue Mao

578 total citations
20 papers, 364 citations indexed

About

Chen‐Xue Mao is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chen‐Xue Mao has authored 20 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 7 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chen‐Xue Mao's work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers) and Cancer-related molecular mechanisms research (4 papers). Chen‐Xue Mao is often cited by papers focused on MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers) and Cancer-related molecular mechanisms research (4 papers). Chen‐Xue Mao collaborates with scholars based in China, United States and Saudi Arabia. Chen‐Xue Mao's co-authors include Ji‐Ye Yin, Zhaoqian Liu, Xiao‐Yuan Mao, Zhibin Wang, Hong‐Hao Zhou, Xi Li, Yuanfeng Gao, Tao Zhu, Ying Zhang and Danfeng Cao and has published in prestigious journals such as International Journal of Molecular Sciences, Molecular Cancer and Cancer Letters.

In The Last Decade

Chen‐Xue Mao

20 papers receiving 354 citations

Peers

Chen‐Xue Mao
Yamei Hu China
Jun Su China
Jianyun Zhou China
Jing Duan China
Li Xy China
Li Ning China
Linlin Ma China
Lenka Weiterová Czechia
Yamei Hu China
Chen‐Xue Mao
Citations per year, relative to Chen‐Xue Mao Chen‐Xue Mao (= 1×) peers Yamei Hu

Countries citing papers authored by Chen‐Xue Mao

Since Specialization
Citations

This map shows the geographic impact of Chen‐Xue Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Xue Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Xue Mao more than expected).

Fields of papers citing papers by Chen‐Xue Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen‐Xue Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Xue Mao. The network helps show where Chen‐Xue Mao may publish in the future.

Co-authorship network of co-authors of Chen‐Xue Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Chen‐Xue Mao. A scholar is included among the top collaborators of Chen‐Xue Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen‐Xue Mao. Chen‐Xue Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Junyan, Qi Xiao, Chen‐Xue Mao, et al.. (2025). GWAS study of myelosuppression among NSCLC patients receiving platinum-based combination chemotherapy. Acta Biochimica et Biophysica Sinica. 57(8). 1281–1291. 1 indexed citations
2.
Yang, Yongmin, et al.. (2024). Systematic analysis of the adverse effects of commonly used clinical tetracycline drugs based on the FAERS database. Expert Opinion on Drug Safety. 24(8). 949–957. 6 indexed citations
3.
Xiao, Qi, Chen‐Xue Mao, Ying Gao, et al.. (2023). Establishing a Prediction Model for the Efficacy of Platinum—Based Chemotherapy in NSCLC Based on a Two Cohorts GWAS Study. Journal of Clinical Medicine. 12(4). 1318–1318. 1 indexed citations
4.
Liu, Xueping, Chen‐Xue Mao, Guansong Wang, & Mingzhou Zhang. (2023). Metagenomic next-generation sequencing for pleural effusions induced by viral pleurisy: A case report. World Journal of Clinical Cases. 11(4). 844–851. 1 indexed citations
5.
Li, Shiying, Jin Tong, Hu Li, et al.. (2023). L. pneumophila Infection Diagnosed by tNGS in a Lady with Lymphadenopathy. Infection and Drug Resistance. Volume 16. 4435–4442. 17 indexed citations
6.
Wang, Yang, Fan Xiao, Yi Zhao, et al.. (2022). A two-stage genome-wide association study to identify novel genetic loci associated with acute radiotherapy toxicity in nasopharyngeal carcinoma. Molecular Cancer. 21(1). 169–169. 8 indexed citations
7.
Wang, Zhibin, Jian Qu, Pan Xie, et al.. (2022). Integrative analysis of expression profile indicates the ECM receptor and LTP dysfunction in the glioma-related epilepsy. BMC Genomics. 23(1). 430–430. 8 indexed citations
8.
9.
Mao, Chen‐Xue, Min Li, Wei Zhang, et al.. (2020). Pharmacogenomics for the efficacy of platinum-based chemotherapy: Old drugs, new integrated perspective. Biomedicine & Pharmacotherapy. 126. 110057–110057. 7 indexed citations
10.
Gao, Yuanfeng, Tao Zhu, Xiao‐Yuan Mao, et al.. (2017). Silencing of Forkhead box D1 inhibits proliferation and migration in glioma cells. Oncology Reports. 37(2). 1196–1202. 34 indexed citations
11.
Mao, Chen‐Xue, et al.. (2017). [Study on the changes of gonadotropin releasing hormone agonist in pinopodes].. PubMed. 52(8). 539–544. 1 indexed citations
12.
Mao, Chen‐Xue, Ji‐Ye Yin, Ying Zhang, et al.. (2017). The molecular classification of astrocytic tumors. Oncotarget. 8(56). 96340–96350. 10 indexed citations
13.
Gao, Yuanfeng, Tao Zhu, Chen‐Xue Mao, et al.. (2016). PPIC, EMP3 and CHI3L1 Are Novel Prognostic Markers for High Grade Glioma. International Journal of Molecular Sciences. 17(11). 1808–1808. 41 indexed citations
14.
Gao, Yuanfeng, Zhibin Wang, Tao Zhu, et al.. (2016). A critical overview of long non-coding RNA in glioma etiology 2016: an update. Tumor Biology. 37(11). 14403–14413. 17 indexed citations
15.
Yin, Ji‐Ye, Xi Li, Xiangping Li, et al.. (2016). Prediction models for platinum-based chemotherapy response and toxicity in advanced NSCLC patients. Cancer Letters. 377(1). 65–73. 20 indexed citations
16.
Gao, Yuanfeng, Xiao‐Yuan Mao, Tao Zhu, et al.. (2016). COL3A1 and SNAP91: novel glioblastoma markers with diagnostic and prognostic value. Oncotarget. 7(43). 70494–70503. 50 indexed citations
17.
Qu, Jian, Ying Zhang, Chen‐Xue Mao, et al.. (2015). Common variants of ATP1A3 but not ATP1A2 are associated with Chinese genetic generalized epilepsies. Journal of the Neurological Sciences. 354(1-2). 56–62. 13 indexed citations
18.
Mao, Xiao‐Yuan, Yonggang Cao, Xi Li, et al.. (2014). Baicalein ameliorates cognitive deficits in epilepsy-like tremor rat. Neurological Sciences. 35(8). 1261–1268. 30 indexed citations
19.
Mao, Xiao‐Yuan, Danfeng Cao, Xi Li, et al.. (2014). Huperzine A Ameliorates Cognitive Deficits in Streptozotocin-Induced Diabetic Rats. International Journal of Molecular Sciences. 15(5). 7667–7683. 69 indexed citations
20.
He, Zhengwen, Jian Qu, Ying Zhang, et al.. (2014). PRRT2 Mutations Are Related to Febrile Seizures in Epileptic Patients. International Journal of Molecular Sciences. 15(12). 23408–23417. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yamei Hu Breakdown of academic impact, for papers by Jun Su Breakdown of academic impact, for papers by Jianyun Zhou Breakdown of academic impact, for papers by Jing Duan Breakdown of academic impact, for papers by Li Xy Breakdown of academic impact, for papers by Li Ning Breakdown of academic impact, for papers by Linlin Ma Breakdown of academic impact, for papers by Lenka Weiterová
Rankless by CCL
2026